quinazolines has been researched along with ozagrel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirawa, N; Numabe, A; Takada, S; Uehara, Y; Yagi, S | 2 |
| Kakinuma, Y; Miyauchi, T | 1 |
1 review(s) available for quinazolines and ozagrel
| Article | Year |
|---|---|
[Endothelin receptor antagonist, phosphodiesterase inhibitor, thromboxane inhibitor].
Topics: Animals; Endothelin Receptor Antagonists; Enzyme Inhibitors; Humans; Hypertension, Pulmonary; Methacrylates; Phosphodiesterase Inhibitors; Piperidines; Purinones; Quinazolines | 2001 |
2 other study(ies) available for quinazolines and ozagrel
| Article | Year |
|---|---|
[Roles of vascular and renal thromboxanes in the antihypertensive effects of alpha 1 adrenoceptor antagonists].
Topics: Adrenergic alpha-Antagonists; Animals; Blood Vessels; Hypertension; Kidney; Male; Methacrylates; Quinazolines; Rats; Rats, Inbred SHR; Thromboxane A2; Thromboxane-A Synthase | 1989 |
Thromboxane inhibition potentiates antihypertensive effects of alpha 1 adrenoceptor antagonists in the rat.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Body Weight; Cells, Cultured; Drug Synergism; Eicosanoids; Ethanolamines; Kidney; Methacrylates; Muscle, Smooth, Vascular; Prazosin; Quinazolines; Rats; Rats, Inbred SHR; Sodium; Thromboxane-A Synthase; Thromboxanes | 1997 |